Minh N. Duong
Epalinges, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib.
Journal: BMC pharmacology & toxicology
Published: September 19, 2019
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Journal: Journal for immunotherapy of cancer
Published: July 19, 2019
TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.
Journal: JCI insight
Published: January 03, 2017
The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance.
Journal: Oncotarget
Published: December 06, 2016
Effect of kinase inhibitors on the therapeutic properties of monoclonal antibodies.
Journal: mAbs
Published: December 20, 2014
Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity.
Journal: Breast cancer research : BCR
Published: December 15, 2014
Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models.
Journal: Molecular cancer therapeutics
Published: July 23, 2013
Bone marrow stem cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 29, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026